Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
A new study finds a combo inhaler cuts asthma attacks in kids by 45% with no growth side effects.
A large international study published in The Lancet found that a combination inhaler with budesonide and formoterol reduces asthma attacks in children aged 5 to 15 by 45% compared to the standard salbutamol inhaler, with no significant differences in growth, lung function, or asthma control.
The CARE study, involving 360 children in New Zealand, showed attack rates dropped from 0.41 to 0.23 per child per year, meaning 18 fewer attacks annually for every 100 children switched.
Researchers say the results support updating global asthma guidelines for children to match adult standards, potentially improving outcomes for millions and reducing care disparities.
Though conducted during the pandemic, the real-world design strengthens the findings, and experts call the treatment a transformative advance in pediatric asthma care.
Un nuevo estudio encuentra que un inhalador combo reduce los ataques de asma en niños en un 45% sin efectos secundarios en el crecimiento.